Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Camizestrant (Estrogen receptor antagonist 2) is an antagonist of the estrogen receptor and can be used in studies about ER+ HER2-advanced breast cancer[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 158.00 | |
5 mg | In stock | $ 397.00 | |
10 mg | In stock | $ 663.00 | |
25 mg | In stock | $ 1,170.00 | |
50 mg | 6-8 weeks | $ 1,890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 416.00 |
Description | Camizestrant (Estrogen receptor antagonist 2) is an antagonist of the estrogen receptor and can be used in studies about ER+ HER2-advanced breast cancer[1]. |
Targets&IC50 | Estrogen Receptor: |
In vivo | In human parental MCF7 mice xenograft, oral administration of Camizestrant (0.2-50 mg/kg) displays dose-dependent anti-tumor effects. Oral administration of Camizestrant (0.8-40 mg/kg) dose-dependently decreases the growth of the tumor[1]. |
Synonyms | Estrogen receptor antagonist 2 |
Molecular Weight | 476.51 |
Formula | C24H28F4N6 |
CAS No. | 2222844-89-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (104.93 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Camizestrant 2222844-89-3 Endocrinology/Hormones Estrogen Receptor/ERR Estrogen receptor antagonist 2 inhibitor inhibit